NEW YORK (GenomeWeb News) — Wafergen BioSystems said today it has landed $1.3 million in a private placement of common stock.
 
Wafergen last week said it had gained $10.7 million in financing as it completed a reverse merger with a shell company.
  
The company said last week it plans to use the proceeds from the investment for corporate infrastructure and product offerings, such as the company’s SmartChip system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.